The Valley Desk

NCT05836259 · Interventional trial

Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Hypertrophic Cardiomyopathy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov